Advertisement
U.S. markets closed
  • S&P Futures

    5,304.25
    -4.00 (-0.08%)
     
  • Dow Futures

    40,140.00
    -36.00 (-0.09%)
     
  • Nasdaq Futures

    18,465.00
    -38.75 (-0.21%)
     
  • Russell 2000 Futures

    2,145.20
    +6.80 (+0.32%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0782
    -0.0012 (-0.11%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • Vix

    13.01
    +0.23 (+1.80%)
     
  • GBP/USD

    1.2622
    -0.0000 (-0.00%)
     
  • USD/JPY

    151.2760
    -0.0960 (-0.06%)
     
  • Bitcoin USD

    70,733.87
    +1,312.17 (+1.89%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,400.54
    +232.47 (+0.58%)
     

Company News for May 24, 2017

•    Shares of Agilent Technologies Inc A advanced 4.6% after the company reported fiscal second-quarter earnings of $0.58 per share, beating the Zacks Consensus Estimate by $0.10

•    Nokia Corporation’s NOK shares gained 5.3% following the news that Apple Inc. AAPL and Nokia Corp. settled a lawsuit over patents

•    Shares of Alexion Pharmaceuticals, Inc. ALXN declined 9.3% following news of departures of the company’s chief commercial officer, chief financial officer and two executive vice presidents

•    Bunge Ltd’s BG shares surged 16.6% after Glencore Plc approached Bunge for a possible takeover
 


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Click for Free Nokia Corporation (NOK) Stock Analysis Report >>
 
Click for Free Apple Inc. (AAPL) Stock Analysis Report >>
 
Click for Free Alexion Pharmaceuticals, Inc. (ALXN) Stock Analysis Report >>
 
Click for Free Agilent Technologies, Inc. (A) Stock Analysis Report >>
 
Click for Free Bunge Limited (BG) Stock Analysis Report >>
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement